Once-daily raltegravir effective as maintenance therapy
HIV rebound linked to higher baseline level, slower suppression and low-level viraemia
Dolutegravir matches or surpasses other regimens for first-line HIV treatment
HCV reinfection is common among HIV-positive gay men in Europe
Late testing rates declining in Europe, but largely in gay men
Tel Aviv and Bucharest signal warnings of new HIV epidemics among people who inject drugs
Future HIV care will include both novel antiretroviral drugs and new treatment strategies
Faldaprevir demonstrates good early response in genotype 1 HIV/HCV co-infection
Suicide rates tumble in people with HIV in Canadian study but psychiatric drug use remains high in Danish people with HIV
Simeprevir with interferon effective for HIV/HCV co-infected people with genotype 1 hepatitis C
Dual therapy with Kaletra and 3TC works well regardless of viral load
GSK1265744 rapidly suppresses HIV and appears safe at selected dose
Ensuring good-quality HIV care in Europe: where can we improve?
New EACS treatment guidelines strike balance between individual choice and public health, say writers
New drugs will bring revolution in hepatitis C treatment
CCR5 inhibitor cenicriviroc shows good activity against HIV; new formulation may reduce dropouts
